Patritumab Deruxtecan Granted U.S. FDA Breakthrough Therapy Designation in Patients with Metastatic EGFR-Mutated Non-Small Cell Lung Cancer
First Breakthrough Therapy Designation for patritumab deruxtecan based on results of phase 1 trial Seventh Breakthrough Therapy Designation granted by...

Real Madrid Head to Greece Seeking Fourth Straight Champions League Win Against AEK Athens
Nabeela Syed flips the Illinois seat Republicans spent a record sum to keep
Court-martial proceedings begin against two Navy officers over INS Brahmaputra capsize
Cabinet grants Agniveers two more years and a wider route into regular forces
Zverev’s No. 1 debut ends in straight sets: what the Musetti loss actually says 





















